Cargando…

Beneficial changes on plasma apolipoproteins A and B, high density lipoproteins and oxidized low density lipoproteins in obese women after bariatric surgery: comparison between gastric bypass and sleeve gastrectomy

BACKGROUND: The beneficial effects in lipid profiles after obesity surgery might be associated with the decrease in cardiovascular risk. However, direct comparison between different surgical techniques has not been extensively performed. METHODS: In the present study we compare 20 obese women submit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Martin, J. M., Balsa, J. A., Aracil, E., Cuadrado-Ayuso, M., Rosillo, M., De la Peña, G., Lasunción, M. A., Escobar-Morreale, H. F., Botella-Carretero, J. I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011580/ https://www.ncbi.nlm.nih.gov/pubmed/29925393 http://dx.doi.org/10.1186/s12944-018-0794-5

Ejemplares similares

Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
por: Aaseth, Jan O., et al.
Publicado: (2022)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
por: Nguyen, David, et al.
Publicado: (2013)

The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
por: Lagor, William R., et al.
Publicado: (2012)

Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients
por: Waldmann, Elisa, et al.
Publicado: (2013)

Low-Density Lipoprotein Receptor Deficiency Attenuates Neuroinflammation through the Induction of Apolipoprotein E
por: Mailleux, Jo, et al.
Publicado: (2017)

Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
por: Li, Ya, et al.
Publicado: (2020)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
por: Tian, Li, et al.
Publicado: (2011)

The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout
por: Rasheed, Humaira, et al.
Publicado: (2014)

Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma
por: Huang, Rong, et al.
Publicado: (2011)

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
por: Gordon, Elizabeth M., et al.
Publicado: (2016)

High Density Lipoproteins and Diabetes
por: Cochran, Blake J., et al.
Publicado: (2021)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Further evidence that high-density lipoprotein is a chameleon-like lipoprotein
por: Fogelman, Alan M.
Publicado: (2015)

Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome
por: Burillo, Elena, et al.
Publicado: (2012)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia
por: Gibbons, Andrew Stuart, et al.
Publicado: (2010)

Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins
por: Zannis, Vassilis I., et al.
Publicado: (2017)

Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2017)

The Role of High Density Lipoproteins in Thrombosis
por: Cuchel, Marina, et al.
Publicado: (2002)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
por: Robert, Jerome, et al.
Publicado: (2020)

Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein
por: Banerjee, D, et al.
Publicado: (1983)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Effects of Evolocumab on Low‐Density Lipoprotein Cholesterol, Non–High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta‐Analysis of Individual Participant Data From Double‐Blind and Open‐Label Extension Studies
por: Daviglus, Martha L., et al.
Publicado: (2020)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes
por: Kusters, D. M., et al.
Publicado: (2011)

Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi‐Ethnic Study of Atherosclerosis
por: Lamprea‐Montealegre, Julio A., et al.
Publicado: (2019)

Quantitative glycoproteomics of high-density lipoproteins
por: Tang, Xinyu, et al.
Publicado: (2022)

Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies
por: Toth, Peter P., et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion
por: Fisher, Eric, et al.
Publicado: (2014)

Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation
por: Hubin, Ellen, et al.
Publicado: (2019)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
por: Pechlaner, Raimund, et al.
Publicado: (2017)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3dbp5lgebskigohbr0re5e7uvj